Global Nanobiotechnology Market size was valued at USD 35.98 Bn. in 2023 and is expected to reach USD 78.55 Bn. by 2030, at a CAGR of 11.8%.Nanobiotechnology Market Overview
Nanobiotechnology is the combination of nanotechnology and the biotechnology field and the study of biological systems at the nanoscale level, typically involving molecules and small particles. Nanobiology and bionanotechnology are other names that are used interchangeably with nanobiotechnology. It involves the application of nanomaterials, nanodevices, and nanoscale techniques to understand, interact with, and control biological processes, leading to a wide range of practical applications across various industries. These sectors are medicine & healthcare, biomedical research institutes, agriculture & food industry, energy & environment companies, IT and others. The increasing use and application of Nanobiotechnology is a key driver for Nanobiotechnology Market growth. North Carolina is a global leader in nanobiotechnology, with universities and industry focused on nanoscience research and applications. Nanobiotechnology is gathering substantial investment from businesses and governments globally. In the healthcare sector, nanobiotechnology is transforming the way diseases are diagnosed and treated. For instance, nanoparticles are being used to deliver drugs directly to cancer cells, thereby minimizing the side effects associated with traditional chemotherapy. This targeted approach to treatment is not only improving patient outcomes but also opening up new markets for pharmaceutical companies. Also, nanobiotechnology is enabling the development of rapid diagnostic tools that detect diseases at their earliest stages, thus facilitating timely intervention and reducing healthcare costs. Pfizer, one of the world's leading pharmaceutical companies, has invested in nanobiotechnology research and startups to explore innovative drug delivery methods and enhance therapeutic outcomes. Key developments include collaborations with nanotechnology companies to create targeted drug delivery systems for cancer treatment and vaccine developmentTo know about the Research Methodology :- Request Free Sample Report
Nanobiotechnology Market Dynamics
1. Key Drivers for the Market Growth: Advancements in Nanomaterials and Nanofabrication Techniques to Boost the Market The continuous advancements in nanomaterials and nanofabrication techniques are expected to drive the global Nanobiotechnology Market. Scientists and engineers have made remarkable progress in designing and synthesizing nanoscale materials with unique properties and functionalities. For example, there is a wide variety of nanostructured materials with different dimensions which range from zero-dimensional (0D) nanoparticles, one-dimensional (1D) nanorods and nanowires, two-dimensional (2D) nanosheets and films, three-dimensional (3D) polycrystals and ultra-nanostructures, and nanoscaffolds. These advancements enable the development of more efficient and targeted drug delivery systems, nanosensors, and other nanobiotechnology-based applications. With improved nanomaterials, researchers are expected to explore novel approaches for diagnosing and treating diseases and are expected to increase the market size and demand. U.S. investments and competitiveness in nanotechnology R&D and challenges to U.S. competitiveness in nanomanufacturing. DARPA invests in high-risk, high-reward research projects, including nanotechnology initiatives, to drive technological breakthroughs that have potential military applications. The NNI fosters collaboration among agencies like the National Science Foundation (NSF), the National Institutes of Health (NIH), the Department of Energy (DOE), and the National Aeronautics and Space Administration (NASA). It provides funding for various research projects and initiatives in nanomaterials, nanofabrication, and other nanotechnology-related areas. Growing Prevalence of Chronic Diseases to Drive the Market Growth The increasing prevalence of chronic diseases across the world including cancer, diabetes, and cardiovascular disorders, is a major growth driver for the Nanobiotechnology Market. Nanobiotechnology provides better solutions for addressing issues regarding traditional treatments for these conditions. Nanoparticle-based drug delivery systems, for instance, enable targeted therapy, reducing side effects and improving patient outcomes. As the global burden of chronic diseases continues to rise, the demand for innovative nanobiotechnology solutions. Academic institutions, private companies and governments of various regions are heavily invested in R & D nanobiotechnology field. This is expected to help with technological advancements, new discoveries, and increased commercialization of nanobiotechnology-based products. These factors can make remarkable growth in the forecast period and the report provides an in-depth explanation with a strong research basis. In 2021, approximately 130 million Americans (45% of the population) had chronic conditions and 61 million (21% of the population) had multiple chronic conditions. Precision medicine, which tailors medical treatment to an individual's unique characteristics, is gaining prominence in the healthcare industry. The ability of nanobiotechnology to deliver drugs directly to the affected tissues or cells, along with its potential to modulate genes or immune responses, is driving the demand for personalized therapies. This focus on precision medicine is expected to be a major growth driver for the Nanobiotechnology Market. 2. Restrain Factors for the Market: Nanobiotechnology use of nanoscale materials, which have unique properties and potential risks. As a result, regulatory agencies have been careful in approving and commercializing nanobiotechnology products. Safety concerns regarding the toxicity and long-term effects of nanomaterials on human health and the environment are expected to increased scrutiny and stringent regulations. Thus, these factors are expected to restrain the Nanobiotechnology Market growth over the forecast period. Also, the ethical implications of gene editing, the privacy of personal genomic data, and equitable access to nanobiotechnology-based healthcare raise ethical debates and public apprehensions are expected to pose a challenge to the industry’s growth. 3. Major Opportunities and Trends of Nanobiotechnology Market a. Nano-Diagnostics and Imaging b. Advancements in Nanosensors c. Gene and Cell Therapies d. Nano-Enabled Agriculture and Food Industry e. Convergence with Artificial Intelligence (AI) and Machine Learning (ML) f. Nanotechnology in Energy Solutions Exploring the Impact of Nanobiotechnology on the Global Business Landscape The rise of nanobiotechnology also presents significant challenges for Nanobiotechnology Market growth. For instance, the development and commercialization of nanotech products require substantial investment in research and development, which is a barrier for small and medium-sized enterprises. The regulatory landscape for nanotech products is still evolving, creating uncertainty for businesses. There are ethical and societal concerns about the potential impacts of nanobiotechnology, which businesses need to address to maintain public trust and acceptance. The biomedical community has at best casual familiarity with recent advancements in nanotechnology. However, the nanotechnology community has potential applications for its newly developed tools and it is a major challenge in biological science.Nanobiotechnology Market Segment Analysis
The Nanobiotechnology Market report provides a segment analysis by therapeutics, application, end-use industry and region. Based on region market is analyzed into major five regions such as North America, APAC, Europe, South America and MEA. Based on End-Use Industry, the pharmaceutical segment held a major Nanobiotechnology Market share in 2023. It involves the application of nanoscale materials, devices, and techniques in the development and delivery of pharmaceutical products. This segment has the potential to revolutionize drug discovery, delivery, and therapeutic efficacy, leading to more targeted and personalized treatments for various diseases. The report provides these factors are how to affect market growth in detail. However, Medical devices segments are expected to grow at a significant CAGR during the forecast period owing to increasing R&D activities by various companies for the development of innovative products using nanoshells or nanoparticles for diagnosis & treatment options in several healthcare areas such as cardiology, oncology & cancer research among others.North America dominated the largest Nanobiotechnology Market share in 2023 and is expected to grow at a CAGR during the forecast period. Well-established regulatory framework provided a conducive environment for the growth of nanobiotechnology. Regulatory agencies in the United States, such as the FDA, worked closely with industry and researchers to ensure the safety and efficacy of nanotech products. Also, the regional market growth is driven by industry collaboration and strong government support. The United States and Canada are at the forefront of nanobiotechnology developments, with numerous academic institutions, research centres, and biotechnology companies driving the progress. Merck KGaA, Ablynx, Johnson & Johnson, Abbott Laboratories, and Novartis AG are some major key players in the region. The Nanobiotechnology industry is competitive, with both established players and stratus leadership positions. Large pharmaceutical companies invested in nanobiotechnology startups and research to expand their product portfolios and stay ahead in the market. Nanomedicine and drug delivery are particularly prominent areas, with advanced clinical trials for cancer therapies and personalized medicine. The region's strong regulatory environment and access to funding have paved the way for significant advancements in the field. Europe market held the second largest Nanobiotechnology Market share in 2023. The high demand for technologically improved products and well-developed R and D facilities are primary factors for regional market growth. Germany and UK market dominated the largest regional market share. Asia Pacific Nanobiotechnology Market is expected to grow at a significant CAGR over the forecast period. The growing focus on research and affordable healthcare solutions is a key driver which is expected to boost market growth. The increasing biotechnology industry, government investments and initiatives, cancer research and targeted therapies, agriculture and environmental applications, and nanotechnology in electronics and materials are some other factors that are expected to drive regional market growth.
Nanobiotechnology Market Regional Insight
Competitive Landscape
The Nanobiotechnology Market involved various companies, research institutions, and universities. Leading players focus on extensive research and development to drive innovation in nanomedicines, nanosensors, and therapeutic applications. They actively engage in strategic partnerships and collaborations with academic institutions and healthcare providers to accelerate product development and commercialization. Market expansion efforts involve establishing a global presence, targeting emerging economies, and obtaining regulatory approvals. Key developments include frequent product launches, mergers, acquisitions, securing funding, and protecting intellectual property. The competitive landscape is characterized by a dynamic interplay of innovation, strategic alliances, and efforts to capitalize on diverse applications across healthcare, agriculture, energy, and the environment.Nanobiotechnology Market Scope: Inquire Before Buying
Global Nanobiotechnology Market Report Coverage Details Base Year: 2023 Forecast Period: 2024-2030 Historical Data: 2018 to 2022 Market Size in 2023: US $ 35.98 Bn. Forecast Period 2024 to 2030 CAGR: 11.8% Market Size in 2030: US $ 78.55 Bn. Segments Covered: By Therapeutics Cancer Dental Cardiac Orthopaedic Others By Application Drug Delivery Systems Diagnostics and Imaging Others By End-Use Industry Pharmaceuticals Medical Devices Medical Research Food and Agriculture Others Nanobiotechnology Market, by Region
North America (United States, Canada and Mexico) Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe) Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC) Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A) South America (Brazil, Argentina Rest of South America)Nanobiotechnology Market Key Players
North America 1. Nami Therapeutics (US) 2. Celgene Corporation (US) 3. Nanophase Technologies Corporation (US) 4. Sigma-Aldrich (US) 5. KGaA, Ablynx (US) 6. Johnson & Johnson(US) 7. Abbott Laboratories(US) 8. Novartis AG(US) Europe 1. Ablynx (Belgium) 2. SkyePharma Pharmaceuticals (France) 3. Nano Bridging Molecules SA (Switzerland) 4. XanTecbioanalytics GmbH (Germany) 5. Nanobiotix(France) Asia Pacific 1. National University of Singapore (NUS) (Singapore) 2. Chinese Academy of Sciences (CAS) (China) 3. National Institute of Advanced Industrial Science and Technology (AIST) (Japan) 4. Indian Institute of Science (IISc) (India) 5. Korea Advanced Institute of Science and Technology (KAIST) (South Korea) 6. Riken Institute (Japan)Frequently Asked Questions:
1] What is the growth rate of the Global Nanobiotechnology Market? Ans. The Global Nanobiotechnology Market is growing at a significant rate of 11.8% during the forecast period. 2] Which region is expected to dominate the Global Nanobiotechnology Market? Ans. North America region is expected to hold the Nanobiotechnology Market growth potential during the forecast period. 3] What is the expected Global Nanobiotechnology Market size by 2030? Ans. The Nanobiotechnology Market size is expected to reach USD 78.55 Bn by 2030. 4] Which are the top players in the Global Nanobiotechnology Market? Ans. The top player of the Nanobiotechnology key player Nami Therapeutics, Celgene Corporation and others. 5] What are the factors driving the Global Nanobiotechnology Market growth? Ans. The growing R and D investment from major players is a key driver for market growth.
1. Nanobiotechnology Market Introduction 1.1. Study Assumption and Market Definition 1.2. Scope of the Study 1.3. Executive Summary 2. Nanobiotechnology Market: Dynamics 2.1. Nanobiotechnology Market Trends by Region 2.1.1. North America Nanobiotechnology Market Trends 2.1.2. Europe Nanobiotechnology Market Trends 2.1.3. Asia Pacific Nanobiotechnology Market Trends 2.1.4. Middle East and Africa Nanobiotechnology Market Trends 2.1.5. South America Nanobiotechnology Market Trends 2.2. Nanobiotechnology Market Dynamics by Region 2.2.1. North America 2.2.1.1. North America Nanobiotechnology Market Drivers 2.2.1.2. North America Nanobiotechnology Market Restraints 2.2.1.3. North America Nanobiotechnology Market Opportunities 2.2.1.4. North America Nanobiotechnology Market Challenges 2.2.2. Europe 2.2.2.1. Europe Nanobiotechnology Market Drivers 2.2.2.2. Europe Nanobiotechnology Market Restraints 2.2.2.3. Europe Nanobiotechnology Market Opportunities 2.2.2.4. Europe Nanobiotechnology Market Challenges 2.2.3. Asia Pacific 2.2.3.1. Asia Pacific Nanobiotechnology Market Drivers 2.2.3.2. Asia Pacific Nanobiotechnology Market Restraints 2.2.3.3. Asia Pacific Nanobiotechnology Market Opportunities 2.2.3.4. Asia Pacific Nanobiotechnology Market Challenges 2.2.4. Middle East and Africa 2.2.4.1. Middle East and Africa Nanobiotechnology Market Drivers 2.2.4.2. Middle East and Africa Nanobiotechnology Market Restraints 2.2.4.3. Middle East and Africa Nanobiotechnology Market Opportunities 2.2.4.4. Middle East and Africa Nanobiotechnology Market Challenges 2.2.5. South America 2.2.5.1. South America Nanobiotechnology Market Drivers 2.2.5.2. South America Nanobiotechnology Market Restraints 2.2.5.3. South America Nanobiotechnology Market Opportunities 2.2.5.4. South America Nanobiotechnology Market Challenges 2.3. PORTER’s Five Forces Analysis 2.4. PESTLE Analysis 2.5. Technology Roadmap 2.6. Regulatory Landscape by Region 2.6.1. North America 2.6.2. Europe 2.6.3. Asia Pacific 2.6.4. Middle East and Africa 2.6.5. South America 2.7. Key Opinion Leader Analysis For Nanobiotechnology Industry 2.8. Analysis of Government Schemes and Initiatives For Nanobiotechnology Industry 2.9. Nanobiotechnology Market Trade Analysis 2.10. The Global Pandemic Impact on Nanobiotechnology Market 3. Nanobiotechnology Market: Global Market Size and Forecast by Segmentation by Demand and Supply Side (by Value in USD Million) 2023-2030 3.1. Nanobiotechnology Market Size and Forecast, by Therapeutics (2023-2030) 3.1.1. Cancer 3.1.2. Dental 3.1.3. Cardiac 3.1.4. Orthopaedic 3.1.5. Others 3.2. Nanobiotechnology Market Size and Forecast, by Application (2023-2030) 3.2.1. Drug Delivery Systems 3.2.2. Diagnostics and Imaging 3.2.3. Others 3.3. Nanobiotechnology Market Size and Forecast, by End-Use Industry (2023-2030) 3.3.1. Pharmaceuticals 3.3.2. Medical Devices 3.3.3. Medical Research 3.3.4. Food and Agriculture 3.3.5. Others 3.4. Nanobiotechnology Market Size and Forecast, by Region (2023-2030) 3.4.1. North America 3.4.2. Europe 3.4.3. Asia Pacific 3.4.4. Middle East and Africa 3.4.5. South America 4. North America Nanobiotechnology Market Size and Forecast by Segmentation (by Value in USD Million) 2023-2030 4.1. North America Nanobiotechnology Market Size and Forecast, by Therapeutics (2023-2030) 4.1.1. Cancer 4.1.2. Dental 4.1.3. Cardiac 4.1.4. Orthopaedic 4.1.5. Others 4.2. North America Nanobiotechnology Market Size and Forecast, by Application (2023-2030) 4.2.1. Drug Delivery Systems 4.2.2. Diagnostics and Imaging 4.2.3. Others 4.3. North America Nanobiotechnology Market Size and Forecast, by End-Use Industry (2023-2030) 4.3.1. Pharmaceuticals 4.3.2. Medical Devices 4.3.3. Medical Research 4.3.4. Food and Agriculture 4.3.5. Others 4.4. North America Nanobiotechnology Market Size and Forecast, by Country (2023-2030) 4.4.1. United States 4.4.1.1. United States Nanobiotechnology Market Size and Forecast, by Therapeutics (2023-2030) 4.4.1.1.1. Cancer 4.4.1.1.2. Dental 4.4.1.1.3. Cardiac 4.4.1.1.4. Orthopaedic 4.4.1.1.5. Others 4.4.1.2. United States Nanobiotechnology Market Size and Forecast, by Application (2023-2030) 4.4.1.2.1. Drug Delivery Systems 4.4.1.2.2. Diagnostics and Imaging 4.4.1.2.3. Others 4.4.1.3. United States Nanobiotechnology Market Size and Forecast, by End-Use Industry (2023-2030) 4.4.1.3.1. Pharmaceuticals 4.4.1.3.2. Medical Devices 4.4.1.3.3. Medical Research 4.4.1.3.4. Food and Agriculture 4.4.1.3.5. Others 4.4.2. Canada 4.4.2.1. Canada Nanobiotechnology Market Size and Forecast, by Therapeutics (2023-2030) 4.4.2.1.1. Cancer 4.4.2.1.2. Dental 4.4.2.1.3. Cardiac 4.4.2.1.4. Orthopaedic 4.4.2.1.5. Others 4.4.2.2. Canada Nanobiotechnology Market Size and Forecast, by Application (2023-2030) 4.4.2.2.1. Drug Delivery Systems 4.4.2.2.2. Diagnostics and Imaging 4.4.2.2.3. Others 4.4.2.3. Canada Nanobiotechnology Market Size and Forecast, by End-Use Industry (2023-2030) 4.4.2.3.1. Pharmaceuticals 4.4.2.3.2. Medical Devices 4.4.2.3.3. Medical Research 4.4.2.3.4. Food and Agriculture 4.4.2.3.5. Others 4.4.3. Mexico 4.4.3.1. Mexico Nanobiotechnology Market Size and Forecast, by Therapeutics (2023-2030) 4.4.3.1.1. Cancer 4.4.3.1.2. Dental 4.4.3.1.3. Cardiac 4.4.3.1.4. Orthopaedic 4.4.3.1.5. Others 4.4.3.2. Mexico Nanobiotechnology Market Size and Forecast, by Application (2023-2030) 4.4.3.2.1. Drug Delivery Systems 4.4.3.2.2. Diagnostics and Imaging 4.4.3.2.3. Others 4.4.3.3. Mexico Nanobiotechnology Market Size and Forecast, by End-Use Industry (2023-2030) 4.4.3.3.1. Pharmaceuticals 4.4.3.3.2. Medical Devices 4.4.3.3.3. Medical Research 4.4.3.3.4. Food and Agriculture 4.4.3.3.5. Others 5. Europe Nanobiotechnology Market Size and Forecast by Segmentation (by Value in USD Million) 2023-2030 5.1. Europe Nanobiotechnology Market Size and Forecast, by Therapeutics (2023-2030) 5.2. Europe Nanobiotechnology Market Size and Forecast, by Application (2023-2030) 5.3. Europe Nanobiotechnology Market Size and Forecast, by End-Use Industry (2023-2030) 5.4. Europe Nanobiotechnology Market Size and Forecast, by Country (2023-2030) 5.4.1. United Kingdom 5.4.1.1. United Kingdom Nanobiotechnology Market Size and Forecast, by Therapeutics (2023-2030) 5.4.1.2. United Kingdom Nanobiotechnology Market Size and Forecast, by Application (2023-2030) 5.4.1.3. United Kingdom Nanobiotechnology Market Size and Forecast, by End-Use Industry (2023-2030) 5.4.2. France 5.4.2.1. France Nanobiotechnology Market Size and Forecast, by Therapeutics (2023-2030) 5.4.2.2. France Nanobiotechnology Market Size and Forecast, by Application (2023-2030) 5.4.2.3. France Nanobiotechnology Market Size and Forecast, by End-Use Industry (2023-2030) 5.4.3. Germany 5.4.3.1. Germany Nanobiotechnology Market Size and Forecast, by Therapeutics (2023-2030) 5.4.3.2. Germany Nanobiotechnology Market Size and Forecast, by Application (2023-2030) 5.4.3.3. Germany Nanobiotechnology Market Size and Forecast, by End-Use Industry (2023-2030) 5.4.4. Italy 5.4.4.1. Italy Nanobiotechnology Market Size and Forecast, by Therapeutics (2023-2030) 5.4.4.2. Italy Nanobiotechnology Market Size and Forecast, by Application (2023-2030) 5.4.4.3. Italy Nanobiotechnology Market Size and Forecast, by End-Use Industry (2023-2030) 5.4.5. Spain 5.4.5.1. Spain Nanobiotechnology Market Size and Forecast, by Therapeutics (2023-2030) 5.4.5.2. Spain Nanobiotechnology Market Size and Forecast, by Application (2023-2030) 5.4.5.3. Spain Nanobiotechnology Market Size and Forecast, by End-Use Industry (2023-2030) 5.4.6. Sweden 5.4.6.1. Sweden Nanobiotechnology Market Size and Forecast, by Therapeutics (2023-2030) 5.4.6.2. Sweden Nanobiotechnology Market Size and Forecast, by Application (2023-2030) 5.4.6.3. Sweden Nanobiotechnology Market Size and Forecast, by End-Use Industry (2023-2030) 5.4.7. Austria 5.4.7.1. Austria Nanobiotechnology Market Size and Forecast, by Therapeutics (2023-2030) 5.4.7.2. Austria Nanobiotechnology Market Size and Forecast, by Application (2023-2030) 5.4.7.3. Austria Nanobiotechnology Market Size and Forecast, by End-Use Industry (2023-2030) 5.4.8. Rest of Europe 5.4.8.1. Rest of Europe Nanobiotechnology Market Size and Forecast, by Therapeutics (2023-2030) 5.4.8.2. Rest of Europe Nanobiotechnology Market Size and Forecast, by Application (2023-2030) 5.4.8.3. Rest of Europe Nanobiotechnology Market Size and Forecast, by End-Use Industry (2023-2030) 6. Asia Pacific Nanobiotechnology Market Size and Forecast by Segmentation (by Value in USD Million) 2023-2030 6.1. Asia Pacific Nanobiotechnology Market Size and Forecast, by Therapeutics (2023-2030) 6.2. Asia Pacific Nanobiotechnology Market Size and Forecast, by Application (2023-2030) 6.3. Asia Pacific Nanobiotechnology Market Size and Forecast, by End-Use Industry (2023-2030) 6.4. Asia Pacific Nanobiotechnology Market Size and Forecast, by Country (2023-2030) 6.4.1. China 6.4.1.1. China Nanobiotechnology Market Size and Forecast, by Therapeutics (2023-2030) 6.4.1.2. China Nanobiotechnology Market Size and Forecast, by Application (2023-2030) 6.4.1.3. China Nanobiotechnology Market Size and Forecast, by End-Use Industry (2023-2030) 6.4.2. S Korea 6.4.2.1. S Korea Nanobiotechnology Market Size and Forecast, by Therapeutics (2023-2030) 6.4.2.2. S Korea Nanobiotechnology Market Size and Forecast, by Application (2023-2030) 6.4.2.3. S Korea Nanobiotechnology Market Size and Forecast, by End-Use Industry (2023-2030) 6.4.3. Japan 6.4.3.1. Japan Nanobiotechnology Market Size and Forecast, by Therapeutics (2023-2030) 6.4.3.2. Japan Nanobiotechnology Market Size and Forecast, by Application (2023-2030) 6.4.3.3. Japan Nanobiotechnology Market Size and Forecast, by End-Use Industry (2023-2030) 6.4.4. India 6.4.4.1. India Nanobiotechnology Market Size and Forecast, by Therapeutics (2023-2030) 6.4.4.2. India Nanobiotechnology Market Size and Forecast, by Application (2023-2030) 6.4.4.3. India Nanobiotechnology Market Size and Forecast, by End-Use Industry (2023-2030) 6.4.5. Australia 6.4.5.1. Australia Nanobiotechnology Market Size and Forecast, by Therapeutics (2023-2030) 6.4.5.2. Australia Nanobiotechnology Market Size and Forecast, by Application (2023-2030) 6.4.5.3. Australia Nanobiotechnology Market Size and Forecast, by End-Use Industry (2023-2030) 6.4.6. Indonesia 6.4.6.1. Indonesia Nanobiotechnology Market Size and Forecast, by Therapeutics (2023-2030) 6.4.6.2. Indonesia Nanobiotechnology Market Size and Forecast, by Application (2023-2030) 6.4.6.3. Indonesia Nanobiotechnology Market Size and Forecast, by End-Use Industry (2023-2030) 6.4.7. Malaysia 6.4.7.1. Malaysia Nanobiotechnology Market Size and Forecast, by Therapeutics (2023-2030) 6.4.7.2. Malaysia Nanobiotechnology Market Size and Forecast, by Application (2023-2030) 6.4.7.3. Malaysia Nanobiotechnology Market Size and Forecast, by End-Use Industry (2023-2030) 6.4.8. Vietnam 6.4.8.1. Vietnam Nanobiotechnology Market Size and Forecast, by Therapeutics (2023-2030) 6.4.8.2. Vietnam Nanobiotechnology Market Size and Forecast, by Application (2023-2030) 6.4.8.3. Vietnam Nanobiotechnology Market Size and Forecast, by End-Use Industry (2023-2030) 6.4.9. Taiwan 6.4.9.1. Taiwan Nanobiotechnology Market Size and Forecast, by Therapeutics (2023-2030) 6.4.9.2. Taiwan Nanobiotechnology Market Size and Forecast, by Application (2023-2030) 6.4.9.3. Taiwan Nanobiotechnology Market Size and Forecast, by End-Use Industry (2023-2030) 6.4.10. Rest of Asia Pacific 6.4.10.1. Rest of Asia Pacific Nanobiotechnology Market Size and Forecast, by Therapeutics (2023-2030) 6.4.10.2. Rest of Asia Pacific Nanobiotechnology Market Size and Forecast, by Application (2023-2030) 6.4.10.3. Rest of Asia Pacific Nanobiotechnology Market Size and Forecast, by End-Use Industry (2023-2030) 7. Middle East and Africa Nanobiotechnology Market Size and Forecast by Segmentation (by Value in USD Million) 2023-2030 7.1. Middle East and Africa Nanobiotechnology Market Size and Forecast, by Therapeutics (2023-2030) 7.2. Middle East and Africa Nanobiotechnology Market Size and Forecast, by Application (2023-2030) 7.3. Middle East and Africa Nanobiotechnology Market Size and Forecast, by End-Use Industry (2023-2030) 7.4. Middle East and Africa Nanobiotechnology Market Size and Forecast, by Country (2023-2030) 7.4.1. South Africa 7.4.1.1. South Africa Nanobiotechnology Market Size and Forecast, by Therapeutics (2023-2030) 7.4.1.2. South Africa Nanobiotechnology Market Size and Forecast, by Application (2023-2030) 7.4.1.3. South Africa Nanobiotechnology Market Size and Forecast, by End-Use Industry (2023-2030) 7.4.2. GCC 7.4.2.1. GCC Nanobiotechnology Market Size and Forecast, by Therapeutics (2023-2030) 7.4.2.2. GCC Nanobiotechnology Market Size and Forecast, by Application (2023-2030) 7.4.2.3. GCC Nanobiotechnology Market Size and Forecast, by End-Use Industry (2023-2030) 7.4.3. Nigeria 7.4.3.1. Nigeria Nanobiotechnology Market Size and Forecast, by Therapeutics (2023-2030) 7.4.3.2. Nigeria Nanobiotechnology Market Size and Forecast, by Application (2023-2030) 7.4.3.3. Nigeria Nanobiotechnology Market Size and Forecast, by End-Use Industry (2023-2030) 7.4.4. Rest of ME&A 7.4.4.1. Rest of ME&A Nanobiotechnology Market Size and Forecast, by Therapeutics (2023-2030) 7.4.4.2. Rest of ME&A Nanobiotechnology Market Size and Forecast, by Application (2023-2030) 7.4.4.3. Rest of ME&A Nanobiotechnology Market Size and Forecast, by End-Use Industry (2023-2030) 8. South America Nanobiotechnology Market Size and Forecast by Segmentation (by Value in USD Million) 2023-2030 8.1. South America Nanobiotechnology Market Size and Forecast, by Therapeutics (2023-2030) 8.2. South America Nanobiotechnology Market Size and Forecast, by Application (2023-2030) 8.3. South America Nanobiotechnology Market Size and Forecast, by End-Use Industry(2023-2030) 8.4. South America Nanobiotechnology Market Size and Forecast, by Country (2023-2030) 8.4.1. Brazil 8.4.1.1. Brazil Nanobiotechnology Market Size and Forecast, by Therapeutics (2023-2030) 8.4.1.2. Brazil Nanobiotechnology Market Size and Forecast, by Application (2023-2030) 8.4.1.3. Brazil Nanobiotechnology Market Size and Forecast, by End-Use Industry (2023-2030) 8.4.2. Argentina 8.4.2.1. Argentina Nanobiotechnology Market Size and Forecast, by Therapeutics (2023-2030) 8.4.2.2. Argentina Nanobiotechnology Market Size and Forecast, by Application (2023-2030) 8.4.2.3. Argentina Nanobiotechnology Market Size and Forecast, by End-Use Industry (2023-2030) 8.4.3. Rest Of South America 8.4.3.1. Rest Of South America Nanobiotechnology Market Size and Forecast, by Therapeutics (2023-2030) 8.4.3.2. Rest Of South America Nanobiotechnology Market Size and Forecast, by Application (2023-2030) 8.4.3.3. Rest Of South America Nanobiotechnology Market Size and Forecast, by End-Use Industry (2023-2030) 9. Global Nanobiotechnology Market: Competitive Landscape 9.1. MMR Competition Matrix 9.2. Competitive Landscape 9.3. Key Players Benchmarking 9.3.1. Company Name 9.3.2. Business Segment 9.3.3. End-user Segment 9.3.4. Revenue (2022) 9.3.5. Company Locations 9.4. Leading Nanobiotechnology Market Companies, by market capitalization 9.5. Market Structure 9.5.1. Market Leaders 9.5.2. Market Followers 9.5.3. Emerging Players 9.6. Mergers and Acquisitions Details 10. Company Profile: Key Players 10.1. Nami Therapeutics (US) 10.1.1. Company Overview 10.1.2. Business Portfolio 10.1.3. Financial Overview 10.1.4. SWOT Analysis 10.1.5. Strategic Analysis 10.1.6. Scale of Operation (small, medium, and large) 10.1.7. Details on Partnership 10.1.8. Regulatory Accreditations and Certifications Received by Them 10.1.9. Awards Received by the Firm 10.1.10. Recent Developments 10.2. Celgene Corporation (US) 10.3. Nanophase Technologies Corporation (US) 10.4. Sigma-Aldrich (US) 10.5. KGaA, Ablynx (US) 10.6. Johnson & Johnson(US) 10.7. Abbott Laboratories(US) 10.8. Novartis AG(US) 10.9. Ablynx (Belgium) 10.10. SkyePharma Pharmaceuticals (France) 10.11. Nano Bridging Molecules SA (Switzerland) 10.12. XanTecbioanalytics GmbH (Germany) 10.13. Nanobiotix(France) 10.14. National University of Singapore (NUS) (Singapore) 10.15. Chinese Academy of Sciences (CAS) (China) 10.16. National Institute of Advanced Industrial Science and Technology (AIST) (Japan) 10.17. Indian Institute of Science (IISc) (India) 10.18. Korea Advanced Institute of Science and Technology (KAIST) (South Korea) 10.19. Riken Institute (Japan) 11. Key Findings 12. Industry Recommendations 13. Nanobiotechnology Market: Research Methodology 14. Terms and Glossary
